The current pandemic is tearing down the regulatory and reimbursement barriers that have prevented telehealth from realizing its full potential to date. Our team examines the value propositions of several telehealth providers as the industry enters the next stage of growth.
Read More
HawkPartners developed a five-step framework to help pharma companies anticipate the “new normal” as a means of optimizing HCP engagement in a post-COVID-19 world.
Read More
With the growing trend of real-world data and real-world evidence in healthcare, what can we expect moving forward? Sharon Mowen explores these applications across the product life cycle and what it means for the future of healthcare decisions.
Read More
Statistics and investments point to pharma companies’ integration of transformative technologies into ways of thinking and doing business. The infographic below, developed by Abbey Ahearn and Lucy Hale, demonstrates the rising emphasis of digital health in pharma.
Read More
Amidst explosive investment in digital health, the industry is working to keep the human side of care front and center.
Read More
Digital health offers tremendous upside for the pharmaceutical industry. In this infographic, we explore the challenges and opportunities ahead for pharma as it innovates to move closer to fully digitized healthcare.
Read More
Abbey Ahearn shares her vision on the (near-term) future of consumer healthcare. Pills with sensors, digital therapeutics for addiction, and AI for early cancer detection are just a few of the coming innovations.
Read More
Three major companies Amazon, JP Morgan and Berkshire Hathaway announced hopes of fixing health care. Here are 4 themes we’ll be watching
Read More
Send this to a friend